Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-21 · accession 0001628280-24-049005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-21 | AMRX | Daly Jason B. | SVP, CLO | S - Sale | $8.40 | -13.7K | 0 | -100% | -$114.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-21 | S | D | 13,665 | $8.40 | 0 | D | — | — |